{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T02:05:39Z","timestamp":1794535539757,"version":"4.9.1"},"reference-count":76,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:p>\n                    Low-grade endometrial stromal sarcomas (LG-ESS) are the second most common malignant uterine mesenchymal tumors, but in contrast to the more common leiomyosarcomas, they are often characterized by a prolonged and relatively indolent course. However, a subset of patients experience significant morbidity or die of disease, and it is difficult to predict which tumors will behave aggressively, with most published studies limited in either the number of tumors or the depth of pathologic parameters evaluated. Thus, we studied the clinicopathologic features of LG-ESS in 102 patients ranging from 21 to 74 (median: 47) years. All were treated with hysterectomy and staged according to both the FIGO 2018 system (stage IA=22, IB=36, I-not otherwise specified=5, II=16, III=13, IV=10) and the FIGO 1988 system (stage I=62, II=1, III=17, IV=22). Tumors measured 1.2-49 (median: 7) cm. Microscopically, 69 involved the endometrium while 33 were centered in the myometrium. Thirteen showed only minimal infiltration of the myometrium while the rest displayed the typical extensive myometrial permeation. The cervical stroma was involved in 18, the uterine serosa in 27, and the parametrium in 22. Conventional morphology resembling proliferative endometrial stroma was seen in 95, fibroblastic appearance in 35, smooth muscle differentiation in 23, sex cord-like differentiation in 21, stromal hyalinization in 21, and myxoid stroma in 9. Less common features included glandular differentiation resembling adenomyosis (n=5), pseudopapillary pattern (n=1), deciduoid appearance (n=2), adipocytic differentiation (n=2), multinucleated cells (n=2), and rhabdomyoblastic differentiation (n=1). Mitoses ranged from &lt;1 to 20 per 10 high-power fields (median=3). Lymphovascular invasion and infarct-type necrosis were present in 64 and 23, respectively. Follow-up was available in all patients ranging from 16 to 358 (median: 79) months. Forty-six received adjuvant treatment as hormonal therapy (n=34), radiation (n=4), radiation and hormonal therapy (n=4), chemotherapy (n=3), or chemotherapy and radiation (n=1). Three patients had persistent unresected tumor following surgery, and an additional 34 had recurrences at intervals of 3 to 272 (median: 79) months, including 2 tumors with minimal infiltration. At last follow-up, 75 patients were alive with no evidence of disease, 14 were alive with disease, and 9 died of disease at intervals of 16 to 167 (median=70) months. Four died of unrelated causes without recurrence. Five-year recurrence-free survival (RFS) and disease-specific survival (DSS) were 80% and 94%, while 10-year RFS and DSS were 51% and 87%, respectively. On statistical analysis, cervical stromal involvement (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    =0.018) and myxoid stroma (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    &lt;0.001) were associated with shorter recurrence-free survival. Tumors lacking a conventional component had worse disease-specific survival (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    =0.048). All other clinical and morphologic features, including stage, were not significantly associated with outcome. On multivariate analysis, only cervical stromal involvement remained an independent predictor of recurrence-free survival (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    =0.047; HR: 16.939) and no factors were independently predictive of disease-specific survival. Our findings highlight the difficulty in predicting outcomes in these tumors, likely due to slow progression and frequent treatment responses even in the recurrent setting. We confirm the potential for recurrence even in tumors initially showing minimal infiltration. Cervical stromal involvement and lack of conventional morphology are potential novel risk factors that should be further evaluated in subsequent studies.\n                  <\/jats:p>","DOI":"10.1097\/pas.0000000000002428","type":"journal-article","created":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T09:00:22Z","timestamp":1748422822000},"page":"977-991","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":11,"title":["Low-Grade Endometrial Stromal Sarcoma"],"prefix":"10.1097","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8097-2437","authenticated-orcid":false,"given":"Kyle M.","family":"Devins","sequence":"first","affiliation":[{"name":"James Homer Wright Pathology Laboratories, Massachusetts General Hospital, Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachelle P.","family":"Mendoza","sequence":"additional","affiliation":[{"name":"Department of Pathology, Columbia University Irving Medical Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Shahi","sequence":"additional","affiliation":[{"name":"Department of Pathology, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariachristina","family":"Ghioni","sequence":"additional","affiliation":[{"name":"Division of Pathology, IEO, European Institute of Oncology IRCCS, Milan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rofieda","family":"Alwaqfi","sequence":"additional","affiliation":[{"name":"Department of Pathology, Johns Hopkins Hospital, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Croce","sequence":"additional","affiliation":[{"name":"Department of Pathology, Institut Bergonie, Bordeaux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Pesci","sequence":"additional","affiliation":[{"name":"Department of Pathology, IRCCS Sacred Heart Hospital, Negrar-Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joana","family":"Ferreira","sequence":"additional","affiliation":[{"name":"Department of Pathology, Instituto Portugues Oncologia de Lisboa Francisco Gentil, Lisbon, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Felix","sequence":"additional","affiliation":[{"name":"Department of Pathology, Instituto Portugues Oncologia de Lisboa Francisco Gentil, Lisbon, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I\u00f1igo","family":"Espinosa","sequence":"additional","affiliation":[{"name":"Department of Pathology, Santa Creu i Sant Pau Hospital, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damiano","family":"Arciuolo","sequence":"additional","affiliation":[{"name":"Department of Pathology, Catholic University of the Sacred Heart, Rome"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gian F.","family":"Zannoni","sequence":"additional","affiliation":[{"name":"Department of Pathology, Catholic University of the Sacred Heart, Rome"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Oliva","sequence":"additional","affiliation":[{"name":"James Homer Wright Pathology Laboratories, Massachusetts General Hospital, Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,5,28]]},"reference":[{"key":"R2-20250917","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1073\/pnas.1115528109","article-title":"14-3-3 fusion oncogenes in high-grade endometrial stromal sarcoma","volume":"109","author":"Lee","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"R3-20250917","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1097\/PAS.0b013e31824a7b1a","article-title":"The clinicopathologic features of YWHAE-FAM22 endometrial stromal sarcomas: A histologically high-grade and clinically aggressive tumor","volume":"36","author":"Lee","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"R4-20250917","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1002\/gcc.22057","article-title":"Fusion of the ZC3H7B and BCOR genes in endometrial stromal sarcomas carrying an X;22-translocation","volume":"52","author":"Panagopoulos","year":"2013","journal-title":"Genes Chromosom Cancer"},{"key":"R5-20250917","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/PAS.0000000000000721","article-title":"Novel high-grade endometrial stromal sarcoma: a morphologic mimicker of myxoid leiomyosarcoma","volume":"41","author":"Hoang","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"R6-20250917","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/PAS.0000000000000993","article-title":"BCOR internal tandem duplication in high-grade uterine sarcomas","volume":"42","author":"Mari\u00f1o-Enriquez","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"R7-20250917","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1038\/s41379-020-0535-y","article-title":"High-grade transformation of low-grade endometrial stromal sarcomas lacking YWHAE and BCOR genetic abnormalities","volume":"33","author":"Zou","year":"2020","journal-title":"Mod Pathol"},{"key":"R8-20250917","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1097\/00000478-199808000-00010","article-title":"Mixed endometrial stromal and smooth muscle tumors of the uterus: a clinicopathologic study of 15 cases","volume":"22","author":"Oliva","year":"1998","journal-title":"Am J Surg Pathol"},{"key":"R9-20250917","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1097\/00000478-200209000-00004","article-title":"Endometrial stromal sarcomas with unusual histologic features: a report of 24 primary and metastatic tumors emphasizing fibroblastic and smooth muscle differentiation","volume":"26","author":"Yilmaz","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"R10-20250917","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/00004347-198402000-00008","article-title":"The clinical and histologic spectrum of endometrial stromal neoplasms: a report of 41 cases","volume":"3","author":"Fekete","year":"1984","journal-title":"Int J Gynecol Pathol"},{"key":"R11-20250917","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1097\/PAS.0b013e318272c612","article-title":"Endometrial stromal sarcomas with sex cord differentiation are associated with PHF1 rearrangement","volume":"37","author":"D\u2019Angelo","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"R12-20250917","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/00004347-199207000-00001","article-title":"Endometrial stromal sarcomas of the uterus with extensive endometrioid glandular differentiation: a report of three cases that caused problems in differential diagnosis","volume":"11","author":"Clement","year":"1992","journal-title":"Int J Gynecol Pathol"},{"key":"R13-20250917","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1365-2559.2009.03230.x","article-title":"Endometrial stromal sarcomas with extensive endometrioid glandular differentiation: report of a series with emphasis on the potential for misdiagnosis and discussion of the differential diagnosis","volume":"54","author":"McCluggage","year":"2009","journal-title":"Histopathology"},{"key":"R14-20250917","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/00004347-199910000-00004","article-title":"Myxoid and fibrous endometrial stromal tumors of the uterus: a report of 10 cases","volume":"18","author":"Oliva","year":"1999","journal-title":"Int J Gynecol Pathol"},{"key":"R15-20250917","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1097\/PGP.0b013e31817a82f9","article-title":"Endometrial stromal sarcomas with true papillae and pseudopapillae","volume":"27","author":"McCluggage","year":"2008","journal-title":"Int J Gynecol Pathol"},{"key":"R16-20250917","first-page":"397","article-title":"A rare case of low-grade endometrial stromal sarcoma with myxoid differentiation and atypical bizarre cells","volume":"29","author":"Kibar","year":"2008","journal-title":"Eur J Gynaecol Oncol"},{"key":"R17-20250917","first-page":"3316","article-title":"Fibromyxoid variant of endometrial stromal sarcoma with atypical bizarre nuclei","volume":"8","author":"Kim","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"R18-20250917","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1097\/01.pas.0000172295.05527.28","article-title":"Unusual morphologic features of endometrial stromal tumors: a report of 2 cases","volume":"29","author":"Baker","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"R19-20250917","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/PAS.0000000000002142","article-title":"Targeted RNA sequencing highlights a diverse genomic and morphologic landscape in low-grade endometrial stromal sarcoma, including novel fusion genes","volume":"48","author":"Kolin","year":"2024","journal-title":"Am J Surg Pathol"},{"key":"R20-20250917","doi-asserted-by":"crossref","first-page":"6348","DOI":"10.1073\/pnas.101132598","article-title":"Frequent fusion of the JAZF1 and JJAZ1 genes in endometrial stromal tumors","volume":"98","author":"Koontz","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"R21-20250917","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S1525-1578(10)60568-5","article-title":"JAZF1\/JJAZ1 gene fusion in endometrial stromal sarcomas","volume":"7","author":"Hrzenjak","year":"2005","journal-title":"J Mol Diagn"},{"key":"R22-20250917","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1136\/ijgc-2022-003383","article-title":"Primary characteristics and outcomes of newly diagnosed low-grade endometrial stromal sarcoma","volume":"32","author":"Smith","year":"2022","journal-title":"Int J Gynecol Cancer"},{"key":"R23-20250917","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ygyno.2023.07.002","article-title":"Clinical characteristics and prognostic factors of endometrial stromal sarcoma and undifferentiated uterine sarcoma confirmed by central pathologic review: A multi-institutional retrospective study from the Japanese Clinical Oncology Group","volume":"176","author":"Kikuchi","year":"2023","journal-title":"Gynecol Oncol"},{"key":"R24-20250917","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1186\/s12885-022-10129-x","article-title":"Clinical characteristics and prognosis analysis of uterine sarcoma: a single\u2011institution retrospective study","volume":"22","author":"Wang","year":"2022","journal-title":"BMC Cancer"},{"key":"R25-20250917","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ygyno.2013.10.029","article-title":"Prognostic factors and outcomes in endometrial stromal sarcoma with the 2009 FIGO staging system: a multicenter review of 114 cases","volume":"132","author":"Yoon","year":"2014","journal-title":"Gynecol Oncol"},{"key":"R26-20250917","doi-asserted-by":"crossref","first-page":"883344","DOI":"10.3389\/fonc.2022.883344","article-title":"Low-grade uterine endometrial stromal sarcoma: Prognostic analysis of clinico-pathological characteristics, surgical management, and adjuvant treatments. Experience from two referral centers","volume":"12","author":"Borella","year":"2022","journal-title":"Front Oncol"},{"key":"R27-20250917","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.ygyno.2017.05.036","article-title":"Low-grade and high-grade endometrial stromal sarcoma: a National Cancer Database study","volume":"146","author":"Seagle","year":"2017","journal-title":"Gynecol Oncol"},{"key":"R28-20250917","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/00000478-199005000-00002","article-title":"Primary uterine endometrial stromal neoplasms: a clinicopathologic study of 117 cases","volume":"14","author":"Chang","year":"1990","journal-title":"Am J Surg Pathol"},{"key":"R29-20250917","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1111\/j.1471-0528.1989.tb03341.x","article-title":"Revised FIGO staging for gynaecological cancer","volume":"96","author":"Shepherd","year":"1989","journal-title":"Br J Obs Gynaecol"},{"key":"R30-20250917","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/ijgo.12613","article-title":"FIGO cancer report 2018: uterine sarcomas","volume":"143","author":"Mbatani","year":"2018","journal-title":"Int J Gynecol Obs"},{"key":"R31-20250917","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1097\/00000478-200205000-00003","article-title":"Endometrial stromal nodules and endometrial stromal tumors with limited infiltration: a clinicopathologic study of 50 cases","volume":"26","author":"Dionigi","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"R32-20250917","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/PGP.0000000000000593","article-title":"Uterine endometrial stromal tumors with limited infiltration: first report of a case series indicating potential for malignant behavior","volume":"39","author":"Moore","year":"2020","journal-title":"Int J Gynecol Pathol"},{"key":"R33-20250917","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2559.1981.tb01761.x","article-title":"Mesenchymal tumours of the uterus. VII. A clinicopathological study of 60 endometrial stromal nodules","volume":"5","author":"Tavassoli","year":"1981","journal-title":"Histopathology"},{"key":"R34-20250917","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1002\/1097-0142(196606)19:6<755::AID-CNCR2820190604>3.0.CO;2-U","article-title":"Mesenchymal tumors of the uterus: a clinical and pathological study of 53 endometrial stromal tumors","volume":"19","author":"Norris","year":"1966","journal-title":"Cancer"},{"key":"R35-20250917","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ejogrb.2017.07.011","article-title":"Endometrial stromal sarcoma: a retropsective analysis of factors affecting recurrence","volume":"216","author":"Agarwal","year":"2017","journal-title":"Eur J Obs Gynecol Reprod Biol"},{"key":"R36-20250917","doi-asserted-by":"crossref","first-page":"31","DOI":"10.5144\/1658-3876.2012.31","article-title":"Endometrial stromal sarcoma: prognostic factors and impact of adjuvant therapy in early stages","volume":"5","author":"Tanz","year":"2012","journal-title":"Hematol Oncol Stem Cell Ther"},{"key":"R37-20250917","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1111\/j.1525-1438.2007.01159.x","article-title":"Low-grade endometrial stromal sarcoma: a single center\u2019s experience with 22 cases","volume":"18","author":"Kim","year":"2008","journal-title":"Int J Gynecol Cancer"},{"key":"R38-20250917","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1053\/j.anndiagpath.2004.10.009","article-title":"Endometrial stromal tumor with limited infiltration and probable extrauterine metastasis: report of a case","volume":"9","author":"Kim","year":"2005","journal-title":"Ann Diagn Pathol"},{"key":"R39-20250917","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1177\/1066896913506934","article-title":"Malignant potential of endometrial stromal tumor with limited infiltration: a case report","volume":"22","author":"Su","year":"2014","journal-title":"Int J Surg Pathol"},{"key":"R40-20250917","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/00004347-200201000-00009","article-title":"Epithelioid endometrial and endometrioid stromal tumors: a report of four cases emphasizing their distinction from epithelioid smooth muscle tumors and other oxyphilic uterine and extrauterine tumors","volume":"21","author":"Oliva","year":"2002","journal-title":"Int J Gynecol Pathol"},{"key":"R41-20250917","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/his.12406","article-title":"Evaluation of fluorescence in-situ hybridization in monomorphic endometrial stromal neoplasms and their histological mimics: a review of 49 cases","volume":"65","author":"Stewart","year":"2014","journal-title":"Histopathology"},{"key":"R42-20250917","doi-asserted-by":"crossref","first-page":"e24502","DOI":"10.1002\/jcla.24502","article-title":"Unusual morphologic features of low-grade endometrial stromal sarcoma: a case report","volume":"36","author":"Meng","year":"2022","journal-title":"J Clin Lab Anal"},{"key":"R43-20250917","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/00004347-199210000-00008","article-title":"Endometrial stromal nodule with smooth and skeletal muscle components similuating stromal sarcoma","volume":"11","author":"Lloreta","year":"1992","journal-title":"Int J Gynecol Pathol1"},{"key":"R44-20250917","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1440-1827.1996.tb03604.x","article-title":"Endometrial stromal sarcoma of the uterus with rhabdoid features","volume":"46","author":"Tanimoto","year":"1996","journal-title":"Pathol Int"},{"key":"R45-20250917","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1365-2559.1996.tb01421.x","article-title":"Endometrial stromal sarcoma with sex cord-like areas and focal rhabdoid differentiation","volume":"29","author":"McCluggage","year":"1996","journal-title":"Histopathology"},{"key":"R46-20250917","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3346\/jkms.1996.11.1.88","article-title":"Uterine endometrial stromal sarcoma with rhabdoid and smooth muscle differentiation","volume":"11","author":"Kim","year":"1996","journal-title":"J Korean Med Sci"},{"key":"R47-20250917","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1002\/1097-0142(19870415)59:8<1494::AID-CNCR2820590817>3.0.CO;2-V","article-title":"Immunocytochemical study of an endometrial diffuse clear cell stromal sarcoma and other endometrial stromal sarcomas","volume":"59","author":"Lifschitz-Mercer","year":"1987","journal-title":"Cancer"},{"key":"R48-20250917","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.anndiagpath.2005.03.002","article-title":"An endometrial stromal tumor with osteoclast-like giant cells","volume":"9","author":"Fadare","year":"2005","journal-title":"Ann Diagn Pathol"},{"key":"R49-20250917","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/00004347-200201000-00008","article-title":"CD10 is a marker for normal and neoplastic endometrial stromal cells","volume":"21","author":"Toki","year":"2002","journal-title":"Int J Gynecol Pathol"},{"key":"R50-20250917","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1186\/s12885-021-08781-w","article-title":"IFITM1, CD10, SMA, and h-caldesmon as a helpful combination in differential diagnosis between endometrial stromal tumor and cellular leiomyoma","volume":"21","author":"Zhao","year":"2021","journal-title":"BMC Cancer"},{"key":"R51-20250917","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/PGP.0b013e318200caff","article-title":"Diagnostic immunohistochemistry in uterine sarcomas: a study of 397 cases","volume":"30","author":"Abeler","year":"2011","journal-title":"Int J Gynecol Pathol"},{"key":"R52-20250917","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/modpathol.3880335","article-title":"Utility of CD10 in distinguishing between endometrial stromal sarcoma and uterine smooth muscle tumors: an immunohistochemical comparison of 34 cases","volume":"14","author":"Chu","year":"2001","journal-title":"Mod Pathol"},{"key":"R53-20250917","doi-asserted-by":"crossref","DOI":"10.1007\/s00428-025-04026-4","article-title":"Immunohistochemical analysis of 147 cases of low-grade endometrial stromal sarcoma: refining the immunohistochemical profile of LG-ESS on a large, molecularly confirmed series","author":"Fl\u00eddrov\u00e1","year":"2025","journal-title":"Virchows Arch"},{"key":"R54-20250917","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/00000478-200204000-00001","article-title":"An immunohistochemical analysis of endometrial stromal and smooth muscle tumors of the uterus: a study of 54 cases emphasizing the importance of using a panel because of overlap in immunoreactivity for individual antibodies","volume":"26","author":"Oliva","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"R55-20250917","first-page":"215","article-title":"Myogenous phenotype of epithelial-like areas in endometrial stromal sarcomas","volume":"115","author":"Lillemoe","year":"1991","journal-title":"Arch Pathol Lab Med"},{"key":"R56-20250917","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1097\/00000478-200104000-00004","article-title":"h-Caldesmon expression effectively distinguishes endometrial stromal tumors from uterine smooth muscle tumors","volume":"25AD","author":"Nucci","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"R57-20250917","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1097\/PGP.0000000000000424","article-title":"IFITM1 outperforms CD10 in differentiating low-grade endometrial stromal sarcomas from smooth muscle neoplasms of the uterus","volume":"37","author":"Busca","year":"2018","journal-title":"Int J Gynecol Pathol"},{"key":"R58-20250917","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1007\/s43032-020-00189-4","article-title":"IFITM1 is a novel, highly sensitive marker for endometriotic stromal cells in ovarian and extragenital endometriosis","volume":"27","author":"Sun","year":"2020","journal-title":"Reprod Sci"},{"key":"R59-20250917","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/01.pas.0000188029.63706.31","article-title":"Use of histone deacetylase 8 (HDAC8), a new marker of smooth muscle differentiation, in the classification of mesenchymal tumors of the uterus","volume":"30","author":"de Leval","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"R60-20250917","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.ygyno.2020.04.001","article-title":"Effect of bilateral salpingo-oophorectomy on the overall survival of premenopausal patients with stage I low-grade endometrial stromal sarcoma; a National Cancer Database analysis","volume":"157","author":"Nasioudis","year":"2020","journal-title":"Gynecol Oncol"},{"key":"R61-20250917","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1097\/01.AOG.0000185511.91694.1e","article-title":"Ovarian preservation in stage I low-grade endometrial stromal sarcomas","volume":"106","author":"Li","year":"2005","journal-title":"Obs Gynecol"},{"key":"R62-20250917","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ygyno.2018.03.008","article-title":"Impact of oophorectomy and hormone suppression in low grade endometrial stromal sarcoma: a multicenter review","volume":"149","author":"Stewart","year":"2018","journal-title":"Gynecol Oncol"},{"key":"R63-20250917","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.ygyno.2010.12.363","article-title":"Incidence of lymph node and adnexal metastasis in endometrial stromal sarcoma","volume":"121","author":"dos Santos","year":"2011","journal-title":"Gynecol Oncol"},{"key":"R64-20250917","first-page":"1363","article-title":"Lymphadenectomy in uterine low-grade endometrial stromal sarcoma: an analysis of 19 cases and a literature review","volume":"20","author":"Signorelli","year":"2010","journal-title":"Int J Gynecol Cancer"},{"key":"R65-20250917","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1007\/s00404-019-05308-4","article-title":"The clinical benefits of hormonal treatment for LG-ESS: a meta-analysis","volume":"300","author":"Ciu","year":"2019","journal-title":"Arch Gynecol Obs"},{"key":"R66-20250917","doi-asserted-by":"crossref","first-page":"608152","DOI":"10.3389\/fonc.2020.608152","article-title":"Adjuvant radiotherapy improved survival in stage I to II low-grade endometrial stromal sarcoma: a retrospective study of 152 cases","volume":"10","author":"Wang","year":"2021","journal-title":"Front Oncol"},{"key":"R67-20250917","doi-asserted-by":"crossref","first-page":"3453","DOI":"10.1245\/s10434-011-1751-y","article-title":"The impact of tumor morcellation during surgery on the outcomes of patients with apparently early low-grade endometrial stromal sarcoma of the uterus","volume":"18","author":"Park","year":"2011","journal-title":"Ann Surg Oncol"},{"key":"R68-20250917","doi-asserted-by":"crossref","first-page":"922757","DOI":"10.3389\/fonc.2022.922757","article-title":"Hormone therapy reduces recurrence in stage II-IV uterine low-grade endometrial stromal sarcomas: a retrospective cohort study","volume":"12","author":"Huang","year":"2022","journal-title":"Front Oncol"},{"key":"R69-20250917","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1111\/jog.14198","article-title":"Long-term impact of lymphadenectomies in patients with low-grade, early-stage uterine endometrial stroma sarcoma","volume":"46","author":"Zhang","year":"2020","journal-title":"J Obs Gynaecol Res"},{"key":"R70-20250917","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1038\/sj.bjc.6604527","article-title":"Endometrial stromal sarcoma: a population-based analysis","volume":"99","author":"Chan","year":"2008","journal-title":"Br J Cancer"},{"key":"R71-20250917","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1365-2559.2009.03231.x","article-title":"Uterine sarcomas in Norway. A histopathological and prognostic survey of a total population from 1970 to 2000 including 419 patients","volume":"54","author":"Abeler","year":"2009","journal-title":"Histopathology"},{"key":"R72-20250917","first-page":"1358","article-title":"Clinical outcomes of uterine sarcomas: results from 14 years worth of experience in the Kinki district in Japan (1990-2003)","volume":"16","author":"Kokawa","year":"2006","journal-title":"Int J Gynecol Cancer"},{"key":"R73-20250917","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ygyno.2010.04.008","article-title":"Stage IA vs. IB endometrial stromal sarcoma: does the new staging system predict survival?","volume":"118","author":"Garg","year":"2010","journal-title":"Gynecol Oncol"},{"key":"R74-20250917","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1006\/gyno.2001.6152","article-title":"Prognostic parameters in endometrial stromal sarcoma: a clinicopathologic study in 31 patients","volume":"81","author":"Bodner","year":"2001","journal-title":"Gynecol Oncol"},{"key":"R75-20250917","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0301-2115(03)00078-2","article-title":"Endometrial stromal sarcoma of the uterus: analysis of 25 patients","volume":"109","author":"Haberal","year":"2003","journal-title":"Eur J Obs Gynecol Reprod Biol"},{"key":"R76-20250917","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1006\/gyno.1996.0224","article-title":"The prognostic significance of surgery, tumor size, malignancy grade, menopausal status, and DNA ploidy in endometrial stromal sarcoma","volume":"62","author":"Nordal","year":"1996","journal-title":"Gynecol Oncol"},{"key":"R77-20250917","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1097\/PAS.0000000000002041","article-title":"Uterine endometrial stromal tumors with pure low-grade morphology harboring YWHAE::NUTM2 fusions: report of a case series emphasizing potential for high-grade transformation and aggressive behavior","volume":"47","author":"Devins","year":"2023","journal-title":"Am J Surg Pathol"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002428","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T05:01:01Z","timestamp":1758085261000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002428"}},"subtitle":["Clinicopathologic and Prognostic Features in a Cohort of 102 Tumors"],"short-title":[],"issued":{"date-parts":[[2025,5,28]]},"references-count":76,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000002428","relation":{},"ISSN":["0147-5185","1532-0979"],"issn-type":[{"value":"0147-5185","type":"print"},{"value":"1532-0979","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,28]]}}}